KalVista Pharmaceuticals, Inc. - KALV
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jun 10, 2026 | SCHEDULE 13G | Glazer Capital, LLC | 4.85% | 2,581,700 | View |
| Jun 10, 2026 | SCHEDULE 13G | Paul J. Glazer | 4.85% | 2,581,700 | View |
| May 21, 2026 | SCHEDULE 13D/A | — | — | — | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 4.2% | 2,136,940 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 4.2% | 2,136,940 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 4.2% | 2,136,940 | View |
| May 13, 2026 | SCHEDULE 13G | SilverArc Capital Management, LLC | 5.6% | 2,876,407 | View |
| May 13, 2026 | SCHEDULE 13G | Devesh Gandhi | 5.6% | 2,876,407 | View |
| May 01, 2026 | SCHEDULE 13G/A | Integrated Core Strategies (US) LLC | 3.0% | 1,546,105 | View |
| May 01, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 3.7% | 1,912,146 | View |
| May 01, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 3.7% | 1,912,146 | View |
| May 01, 2026 | SCHEDULE 13G/A | Israel A. Englander | 3.7% | 1,912,146 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.